Sabre Corporation

As of June 30, 2026, Sabre Corporation carries a market capitalization of 736.71M, placing it among publicly traded companies globally. Its enterprise value stands at 3.95B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Sabre Corporation's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Sabre Corporation has 403.57M shares outstanding.

As of June 30, 2026, Sabre Corporation trades at a trailing price-to-earnings ratio of 1.15. The price-to-sales ratio is 0.29, and the price-to-book ratio stands at -0.79.

As of June 30, 2026, Sabre Corporation trades at an EV/EBITDA multiple of 10.44 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.58 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 13.93 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 3.95B versus a market cap of 736.71M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Sabre Corporation maintains a current ratio of 1.02, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -413.52, indicating conservative leverage, while an interest coverage ratio of 0.91 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) stands at 16.32, measuring how efficiently the asset base is converted into earnings. The company generates approximately 494,600.17 in revenue per employee across its workforce of 5,050.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Sabre Corporation recorded an income tax benefit of -55.20M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -123.53M and 628.12M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Sabre Corporation's stock has declined approximately 27.89% over the past 52 weeks. The 50-day moving average sits at 1.79, while the 200-day moving average is 1.50.

Over the twelve months ended June 30, 2026, Sabre Corporation generated 2.50B in revenue and converted that into 628.12M in net income, yielding earnings per share of -0.17. EBITDA reached 378.20M, while operating income came in at 283.30M.

As of June 30, 2026, Sabre Corporation holds 591.68M in cash and equivalents against 3.78B in total debt, resulting in a net debt position of 3.19B. Total book value stands at -936.86M, with working capital of 24.66M providing operational flexibility.

Sabre Corporation produced 65.77M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -79.98M in capital expenditures, free cash flow totaled -14.21M - equivalent to -0.04 per share.

Over the twelve months ended June 30, 2026, Sabre Corporation posted a gross margin of 31.31, reflecting its pricing power and cost economics. The operating margin of 11.34 and net profit margin of 25.14 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -1.92: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 93.76, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Sabre Corporation shareholders.

As of June 30, 2026, Sabre Corporation has an Altman Z-Score of -0.72, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.